Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-08-07 | 2024-06 | 0 | -0.24 | N/A | N/A |
2024-05-08 | 2024-03 | 0 | -0.6 | N/A | N/A |
2024-05-08 | 2024-03 | 0 | N/A | N/A | N/A |
2024-03-05 | 2023-12 | 0 | -0.96 | N/A | N/A |
2024-03-05 | 2023-12 | 0 | N/A | N/A | N/A |
2023-11-08 | 2023-09 | -0.75 | -1.48 | -0.73 | -97.33% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-09 | BTIG | Upgrade | Buy | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2022-07-06 | BARKER DAVID L | Director | 58.36K | Conversion of Exercise of derivative security |
2024-06-02 | CHAUBEY ALKA PH.D. | Officer | 48.25K | Stock Award(Grant) |
2024-06-02 | DIXON JONATHAN V | General Counsel | 18.02K | Stock Award(Grant) |
2024-06-02 | HOLMLIN R ERIK | Chief Executive Officer | 122.32K | Stock Award(Grant) |
2024-06-02 | KAMA GULSEN | Chief Financial Officer | 16.00K | Stock Award(Grant) |
2022-08-14 | LINNEY YVONNE | Director | 0.00 | Sale |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 1.45M | 885.53K | 4.11% |
2023-06-29 | Blackrock Inc. | 613.69K | 374.35K | 1.74% |
2023-06-29 | Qube Research & Technologies Ltd | 393.95K | 240.31K | 1.11% |
2023-06-29 | State Street Corporation | 383.77K | 234.10K | 1.09% |
2023-06-29 | Mitsubishi UFJ Kokusai Asset Management Co., Ltd | 358.95K | 218.96K | 1.02% |
2023-06-29 | Millennium Management Llc | 333.07K | 203.17K | 0.94% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 889.85K | 542.81K | 2.52% |
2023-06-29 | Vanguard Extended Market Index Fund | 406.54K | 247.99K | 1.15% |
2023-08-30 | SPDR (R) Ser Tr-SPDR� Kensho New Economies Composite ETF | 258.12K | 996.34K | 0.73% |
2023-05-30 | Fidelity Extended Market Index Fund | 152.01K | 105.18K | 0.43% |
2023-09-29 | Global X Fds-Global X Genomics & Biotechnology ETF | 136.15K | 412.53K | 0.39% |
2023-05-30 | Schwab Strategic Tr-Schwab U.S. Small Cap ETF | 125.49K | 86.83K | 0.36% |
Split | Date |
---|---|
1 : 10 | 2023-08-07 |
-
-
-
-
-
-
-
Sold that slipping/sliding shit be patient? Nah...
-
-
$BNGO good week ahead
-
$BNGO Investors might want to bet on Bionano Genomics, Inc. (BNGO - Free Report) , as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices
-
$BNGO excited for this week.
-
$BNGO nice close
-
$BNGO. I wouldn’t want to be out over the weekend. Monday rocket
-
$BNGO low volume
-
$BNGO. Be stupid and sell for a loss if you want lol. Then go to the next stock and repeat. Next thing you know, you’re broke. Don’t be that guy
-
$BNGO Bionano Genomics launched the largest study to date to identify genomic variants and novel active substances that influence resistance or sensitivity to the novel coronavirus that causes COVID-19. The first study is underway in Wuhan, China. The Hannover Medical School is now launching a study involving 1,000 patients and controls.
-
$BNGO. Buyout ready.
-
$BGNO. These prices are a gift.
-
Please if you could all shut your fucking big mouth up and stop saying bullshit about the predictions of prices!!!
-
$BNGO solid close...
-
Are Value Hunters Buying Bionano Genomics Inc (NASDAQ: BNGO) Stock?
news.google.com • -
Bionano to Present at the Canaccord Genuity 44th Annual Growth Conference
globenewswire.com • -
3 Sorry Healthcare Stocks to Sell in May While You Still Can
investorplace.com • -
Lab Instrument Industry Update - New Commercial Entrants
seekingalpha.com • -
The 3 Best Healthcare Stocks to Buy in May 2024
investorplace.com • -
Bionano Genomics, Inc. (BNGO) Q1 2024 Earnings Call Transcript
seekingalpha.com • -
3 Contrarian Investments to Make Now for Massive Upside Potential
investorplace.com •